Published in Plant Physiol on April 01, 1935
RELATION OF SULPHUR DIOXIDE IN THE ATMOSPHERE TO PHOTOSYNTHESIS AND RESPIRATION OF ALFALFA. Plant Physiol (1937) 4.00
Mechanisms of resistance to sulfur dioxide in the Cucurbitaceae. Plant Physiol (1978) 2.04
Fusicoccin and Air Pollutant Injury to Plants : Evidence for Enhancement of SO(2) but Not O(3) Injury. Plant Physiol (1984) 0.90
INFLUENCE OF LEAF DESTRUCTION BY SULPHUR DIOXIDE AND BY CLIPPING ON YIELD OF ALFALFA. Plant Physiol (1933) 10.41
THE CONTINUOUS MEASUREMENT OF PHOTOSYNTHESIS, RESPIRATION, AND TRANSPIRATION OF ALFALFA AND WHEAT GROWING UNDER FIELD CONDITIONS. Plant Physiol (1937) 11.51
RELATION OF SULPHUR DIOXIDE IN THE ATMOSPHERE TO PHOTOSYNTHESIS AND RESPIRATION OF ALFALFA. Plant Physiol (1937) 4.00
A STUDY OF THE SULPHUR METABOLISM OF WHEAT, BARLEY AND CORN USING RADIOACTIVE SULPHUR. Plant Physiol (1944) 2.90
AN INSTALLATION OF LARGE SAND-CULTURE BEDS SURMOUNTED BY INDIVIDUAL AIR-CONDITIONED GREENHOUSES. Plant Physiol (1943) 2.47
Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest (1998) 2.14
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest (2001) 1.91
APPARENT EQUILIBRIUM BETWEEN PHOTOSYNTHESIS AND RESPIRATION IN AN UNRENEWED ATMOSPHERE. Plant Physiol (1944) 1.56
SOME CHEMICAL REACTIONS OF SULPHUR DIOXIDE AFTER ABSORPTION BY ALFALFA AND SUGAR BEETS. Plant Physiol (1944) 1.48
RADIOAUTOGRAPHS SHOWING THE DISTRIBUTION OF SULPHUR IN WHEAT. Plant Physiol (1944) 1.46
IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation. J Clin Invest (1999) 1.44
Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease. Blood (1999) 1.36
THE UTILIZATION OF SULPHATE AND SULPHUR DIOXIDE FOR THE SULPHUR NUTRITION OF ALFALFA. Plant Physiol (1943) 1.35
Cytokine cascades in acute graft-versus-host disease. Transplantation (1997) 1.31
Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation (2000) 1.27
Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level. J Exp Med (1999) 1.22
Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation. Cancer Res (2001) 1.15
Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: potential role for a gut-lung axis of inflammation. J Immunol (2000) 1.05
G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient. Transplantation (2000) 0.96
Combination antithymocyte globulin and soluble TNFalpha inhibitor (etanercept) +/- mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease. Bone Marrow Transplant (2006) 0.94
High affinity binding of [3H]epibatidine to rat brain membranes. Neuroreport (1999) 0.88
Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide. Bone Marrow Transplant (2000) 0.88
Impact of cytokine gene polymorphisms on graft-vs-host disease. Tissue Antigens (2008) 0.79
Immunotherapy following relapse of acute leukaemia after T-cell-replete allogeneic peripheral blood progenitor cell transplantation: importance of new onset chronic graft-versus-host disease. Int J Lab Hematol (2013) 0.78
Dendritic cell immunotherapy for cancer: application to low-grade lymphoma and multiple myeloma. Immunol Cell Biol (1999) 0.78
Twenty-four hour continuous infusion of amphotericin B for the treatment of suspected or proven fungal infection in haematology patients. Intern Med J (2005) 0.75
Congenital dyserythropoiesis with intererythroblastic chromatin bridges and ultrastructurally-normal erythroblast heterochromatin: a new disorder. Br J Haematol (1998) 0.75
Bruising associated with sibutramine: results from postmarketing surveillance in New Zealand. Int J Obes (Lond) (2006) 0.75